angiotensin ii has been researched along with Experimental Hepatoma in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (38.46) | 18.7374 |
| 1990's | 11 (42.31) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, W; Wu, HX; Xu, ZW; Yan, SX; Zhang, Y | 1 |
| Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Dixon, KA; Gupta, S; Han, L; Johnson, VE; Kan, Z; Kundra, V; Liu, P; Ravoori, MK; Singh, SP; Wright, KC | 1 |
| Cook, JL; Giardina, JF; Re, RN; Zhang, Z | 1 |
| Erdstein, J; Guyda, HJ; Mishkin, S | 1 |
| Abe, I; Hori, K; Saito, S; Sato, H; Suzuki, M | 2 |
| Grigor, MR; Low, BC | 1 |
| Gao, XL; Li, YL; Yu, HZ | 1 |
| Carrière, S; Chan, JS; Delalandre, A; Lachance, S; Ming, M; Wu, J | 1 |
| Hori, K; Li, HC; Saito, S; Suzuki, M; Tanda, S; Zhang, QH | 1 |
| Li, HC; Li, YL; Zhang, LH | 1 |
| Sitzmann, JV; Wu, Y | 1 |
| Allen-Mersh, TG; Carnochan, P; Deehan, B; Dworkin, MJ; Zweit, J | 1 |
| Alzuguren, P; Bilbao, R; Bustos, M; Drozdzik, M; Pajares, MJ; Prieto, J; Qian, C | 1 |
| Hori, K; Saito, S; Suzuki, M; Tanda, S | 1 |
| Hori, K; Saito, S; Shinozaki, M; Suzuki, M; Tanda, S; Zhang, QH | 1 |
| Hori, K; Li, YL; Saito, S; Suzuki, M; Tanda, S | 1 |
| Chang, D; Cooke, TG; Grime, SJ; Hemingway, DM; Jenkins, SA | 1 |
| Aoki, K; Baba, T; Hasuda, K; Kobayashi, H; Taniguchi, S | 1 |
| Burton, MA; Coletti, A; Gray, BN | 1 |
| Hoshi, M; Sato, H; Sugiyama, K; Urushiyama, M; Wakui, A | 1 |
| Abe, I; Hori, K; Saito, S; Suzuki, M | 3 |
| Burton, MA; Gray, BN; Heggie, JC; Self, GW; Townsend, PS | 1 |
26 other study(ies) available for angiotensin ii and Experimental Hepatoma
| Article | Year |
|---|---|
Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expression.
Topics: Angiotensin II; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Disease Progression; Down-Regulation; G-Protein-Coupled Receptor Kinase 2; Humans; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Receptor, Angiotensin, Type 1; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha | 2019 |
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles | 2011 |
Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Contrast Media; Image Enhancement; Infusions, Intralesional; Liver Circulation; Liver Neoplasms, Experimental; Perfusion Imaging; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasoconstrictor Agents | 2011 |
Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells.
Topics: Amides; Amino Acid Sequence; Angiotensin II; Animals; Carboxypeptidase H; Carboxypeptidases; Cold Temperature; Disulfiram; Enzyme Precursors; Fatty Acids, Monounsaturated; Genes, Reporter; Green Fluorescent Proteins; Intracellular Fluid; Liver Neoplasms, Experimental; Losartan; Luminescent Proteins; Mixed Function Oxygenases; Molecular Sequence Data; Multienzyme Complexes; Mutagenesis, Site-Directed; Neoplasm Proteins; Peptide Fragments; Plasmids; Platelet-Derived Growth Factor; Protein Folding; Protein Processing, Post-Translational; Protein Sorting Signals; Rats; RNA, Messenger; RNA, Neoplasm; Transfection; Tumor Cells, Cultured | 2002 |
Effects of hypophysectomy and hormone replacement on the local and metastatic growth of Morris hepatoma 44.
Topics: Angiotensin II; Animals; Cell Membrane; Female; Growth Hormone; Hypophysectomy; Kinetics; Liver Neoplasms, Experimental; Lung Neoplasms; Prolactin; Rats; Rats, Inbred BUF; Receptors, Cell Surface; Thyroxine | 1984 |
A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Bone Marrow; Liver Neoplasms, Experimental; Lymphatic Metastasis; Male; Mitomycins; Neoplasm Metastasis; Rats; Regional Blood Flow | 1981 |
Selective increase in tumor oxygen tension with angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Liver Neoplasms, Experimental; Male; Oxygen; Partial Pressure; Rats; Regional Blood Flow | 1982 |
Angiotensin II stimulates system y+ and cationic amino acid transporter gene expression in cultured vascular smooth muscle cells.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Aorta; Arginine; Base Sequence; Biological Transport; Carrier Proteins; Cells, Cultured; Cloning, Molecular; Cycloheximide; Dactinomycin; DNA Primers; DNA, Complementary; Gene Expression; Kinetics; Liver Neoplasms, Experimental; Lysine; Membrane Glycoproteins; Membrane Proteins; Mice; Molecular Sequence Data; Muscle, Smooth, Vascular; Rats; Receptors, Virus; Sequence Homology, Amino Acid | 1995 |
[Tumor microvascular bed and its reactivity to vasoactive agents: measurement of tissue blood flow and patho-morphological study].
Topics: Angiotensin II; Animals; Liver Circulation; Liver Neoplasms, Experimental; Male; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Rats | 1994 |
Beta-adrenergic receptors and angiotensinogen gene expression in mouse hepatoma cells in vitro.
Topics: Angiotensin II; Angiotensinogen; Animals; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Gene Expression Regulation; Isoproterenol; Liver Neoplasms, Experimental; Mice; Propranolol; Receptors, Adrenergic, beta; Tumor Cells, Cultured | 1995 |
Changes in vessel pressure and interstitial fluid pressure of normal subcutis and subcutaneous tumor in rats due to angiotensin II.
Topics: Angiotensin II; Animals; Cell Division; Extracellular Space; Liver Neoplasms, Experimental; Male; Microcirculation; Neoplasm Transplantation; Pressure; Rats; Rats, Inbred Strains; Reference Values; Skin; Transplantation, Heterotopic; Venous Pressure | 1994 |
[The effects of angiotensin II and other vasoactive agents on the blood flow in Yoshida ascites hepatoma].
Topics: Angiotensin II; Animals; Epinephrine; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Norepinephrine; Rats; Regional Blood Flow; Sympathomimetics | 1993 |
Pharmacokinetics of regional angiotensin-II: a novel biologic response modifier.
Topics: Angiotensin II; Animals; Drug Administration Routes; Hemodynamics; Liver Neoplasms, Experimental; Rats; Rats, Inbred ACI; Vasoconstrictor Agents | 1996 |
Effect of regional angiotensin II infusion on the relationship between tumour blood flow and fluorouracil uptake in a liver metastasis animal model.
Topics: Analysis of Variance; Angiotensin II; Animals; Antimetabolites, Antineoplastic; Blood Flow Velocity; Fluorouracil; Liver Neoplasms, Experimental; Male; Radioactive Tracers; Rats; Vasoconstrictor Agents | 1996 |
A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds.
Topics: Actins; Adenoviridae; Angiotensin II; Animals; Diethylnitrosamine; Extracellular Matrix; Fibronectins; Gene Expression; Genetic Therapy; Genetic Vectors; Immunohistochemistry; Injections, Intra-Arterial; Lac Operon; Laminin; Liver Neoplasms, Experimental; Microspheres; Nitroglycerin; Portal System; Rats; Rats, Wistar; Starch; Transfection; Vasodilator Agents | 2000 |
[Development of the angioarchitecture and microcirculatory characteristics in rat tumor].
Topics: Angiotensin II; Animals; Blood Pressure; Liver Neoplasms, Experimental; Male; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Rats; Rats, Inbred Strains; Regional Blood Flow | 1990 |
Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension.
Topics: Anesthesia, Inhalation; Angiotensin II; Animals; Blood Pressure; Hypertension; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Regional Blood Flow; Sarcoma, Experimental; Time Factors | 1991 |
[The effects of angiotensin II and other noradrenergic vasoconstrictors on the blood flow in Yoshida rat ascites hepatoma AH 109 A at same electrode position].
Topics: Adrenergic Agonists; Angiotensin II; Animals; Blood Pressure; Electrodes, Implanted; Hydrogen; Liver Neoplasms, Experimental; Male; Methoxamine; Rats; Rats, Inbred Strains; Regional Blood Flow; Vasoconstrictor Agents | 1990 |
The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour.
Topics: Angiotensin II; Animals; Blood Pressure; Infusions, Intravenous; Injections, Intra-Arterial; Liver Circulation; Liver Neoplasms, Experimental; Male; Phenylephrine; Rats; Technetium Tc 99m Medronate; Vasoconstrictor Agents | 1991 |
Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II for rat liver tumor.
Topics: Angiotensin II; Animals; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Cisplatin; Female; Liver Neoplasms, Experimental; Platinum; Rats; Rats, Inbred Strains; Thiosulfates | 1989 |
Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma.
Topics: Angiotensin II; Animals; Carcinoma, Squamous Cell; Liver; Liver Neoplasms, Experimental; Microspheres; Neoplasm Transplantation; Sheep | 1988 |
[Increase of blood flow in human tumor tissue under angiotensin II-induced hypertension].
Topics: Adenocarcinoma; Angiotensin II; Animals; Blood Pressure; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains; Regional Blood Flow; Stomach Neoplasms | 1987 |
[Functional characterization of microcirculation in tumors: chemotherapeutic implications].
Topics: Angiotensin II; Animals; Antineoplastic Agents; Blood Pressure; Humans; Injections, Intravenous; Liver Neoplasms, Experimental; Microcirculation; Rats | 1985 |
[Enhancement of vascular level in tumors under angiotensin-induced hypertension].
Topics: Angiotensin II; Animals; Blood Pressure; Liver Circulation; Liver Neoplasms, Experimental; Male; Microcirculation; Rats; Rats, Inbred Strains | 1985 |
[Changes in tumor transvascular pressure difference associated with tumor growth: implications for angiotensin-induced hypertension chemotherapy].
Topics: Angiotensin II; Animals; Antineoplastic Agents; Blood Pressure; Capillaries; Liver Neoplasms, Experimental; Male; Partial Pressure; Plethysmography; Rats; Rats, Inbred Strains; Transducers, Pressure | 1985 |
Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Liver Neoplasms, Experimental; Rabbits; Rats; Rats, Inbred Strains; Regional Blood Flow | 1985 |